STZ Quote, Financials, Valuation and Earnings

Brown-Forman Corp. has a net margin of 23.5% compared to Constellation Brands, Inc.'s net margin of 21.52%. Constellation Brands, Inc.'s return on equity of 15.08% beat Brown-Forman Corp.'s return on equity of 20.62%.

Constellation Brands, Inc. has a consensus price target of $170.73, signalling upside risk potential of 16.02%. On the other hand Brown-Forman Corp. has an analysts' consensus of $30.96 which suggests that it could grow by 19.28%. Given that Brown-Forman Corp. has higher upside potential than Constellation Brands, Inc., analysts believe Brown-Forman Corp. is more attractive than Constellation Brands, Inc..

Constellation Brands, Inc. has a beta of 0.447, which suggesting that the stock is 55.311% less volatile than S&P 500. In comparison Brown-Forman Corp. has a beta of 0.417, suggesting its less volatile than the S&P 500 by 58.343%.

Constellation Brands, Inc. has a quarterly dividend of $1.02 per share corresponding to a yield of 2.77%. Brown-Forman Corp. offers a yield of 3.51% to investors and pays a quarterly dividend of $0.23 per share. Constellation Brands, Inc. pays 2353.06% of its earnings as a dividend. Brown-Forman Corp. pays out 48.36% of its earnings as a dividend. Brown-Forman Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Constellation Brands, Inc.'s is not.

Constellation Brands, Inc. quarterly revenues are $2.2B, which are larger than Brown-Forman Corp. quarterly revenues of $1B. Constellation Brands, Inc.'s net income of $522.2M is higher than Brown-Forman Corp.'s net income of $224M. Notably, Constellation Brands, Inc.'s price-to-earnings ratio is 23.18x while Brown-Forman Corp.'s PE ratio is 15.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Constellation Brands, Inc. is 2.78x versus 3.16x for Brown-Forman Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Keurig Dr Pepper, Inc. has a net margin of 23.5% compared to Constellation Brands, Inc.'s net margin of 15.37%. Constellation Brands, Inc.'s return on equity of 15.08% beat Keurig Dr Pepper, Inc.'s return on equity of 6.38%.

Constellation Brands, Inc. has a consensus price target of $170.73, signalling upside risk potential of 16.02%. On the other hand Keurig Dr Pepper, Inc. has an analysts' consensus of $34.13 which suggests that it could grow by 22.83%. Given that Keurig Dr Pepper, Inc. has higher upside potential than Constellation Brands, Inc., analysts believe Keurig Dr Pepper, Inc. is more attractive than Constellation Brands, Inc..

Constellation Brands, Inc. has a beta of 0.447, which suggesting that the stock is 55.311% less volatile than S&P 500. In comparison Keurig Dr Pepper, Inc. has a beta of 0.342, suggesting its less volatile than the S&P 500 by 65.828%.

Constellation Brands, Inc. has a quarterly dividend of $1.02 per share corresponding to a yield of 2.77%. Keurig Dr Pepper, Inc. offers a yield of 3.31% to investors and pays a quarterly dividend of $0.23 per share. Constellation Brands, Inc. pays 2353.06% of its earnings as a dividend. Keurig Dr Pepper, Inc. pays out 84.51% of its earnings as a dividend. Keurig Dr Pepper, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Constellation Brands, Inc.'s is not.

Constellation Brands, Inc. quarterly revenues are $2.2B, which are smaller than Keurig Dr Pepper, Inc. quarterly revenues of $4.3B. Constellation Brands, Inc.'s net income of $522.2M is lower than Keurig Dr Pepper, Inc.'s net income of $662M. Notably, Constellation Brands, Inc.'s price-to-earnings ratio is 23.18x while Keurig Dr Pepper, Inc.'s PE ratio is 23.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Constellation Brands, Inc. is 2.78x versus 2.34x for Keurig Dr Pepper, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Boston Beer Co., Inc. has a net margin of 23.5% compared to Constellation Brands, Inc.'s net margin of 8.59%. Constellation Brands, Inc.'s return on equity of 15.08% beat Boston Beer Co., Inc.'s return on equity of 9.92%.

Constellation Brands, Inc. has a consensus price target of $170.73, signalling upside risk potential of 16.02%. On the other hand Boston Beer Co., Inc. has an analysts' consensus of $241.01 which suggests that it could grow by 15.97%. Given that Constellation Brands, Inc. has higher upside potential than Boston Beer Co., Inc., analysts believe Constellation Brands, Inc. is more attractive than Boston Beer Co., Inc..

Constellation Brands, Inc. has a beta of 0.447, which suggesting that the stock is 55.311% less volatile than S&P 500. In comparison Boston Beer Co., Inc. has a beta of 1.039, suggesting its more volatile than the S&P 500 by 3.867%.

Constellation Brands, Inc. has a quarterly dividend of $1.02 per share corresponding to a yield of 2.77%. Boston Beer Co., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Constellation Brands, Inc. pays 2353.06% of its earnings as a dividend. Boston Beer Co., Inc. pays out -- of its earnings as a dividend.

Constellation Brands, Inc. quarterly revenues are $2.2B, which are larger than Boston Beer Co., Inc. quarterly revenues of $537.5M. Constellation Brands, Inc.'s net income of $522.2M is higher than Boston Beer Co., Inc.'s net income of $46.2M. Notably, Constellation Brands, Inc.'s price-to-earnings ratio is 23.18x while Boston Beer Co., Inc.'s PE ratio is 24.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Constellation Brands, Inc. is 2.78x versus 1.17x for Boston Beer Co., Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Molson Coors Beverage Co. has a net margin of 23.5% compared to Constellation Brands, Inc.'s net margin of -98.77%. Constellation Brands, Inc.'s return on equity of 15.08% beat Molson Coors Beverage Co.'s return on equity of -16.14%.

Constellation Brands, Inc. has a consensus price target of $170.73, signalling upside risk potential of 16.02%. On the other hand Molson Coors Beverage Co. has an analysts' consensus of $50.95 which suggests that it could grow by 5.86%. Given that Constellation Brands, Inc. has higher upside potential than Molson Coors Beverage Co., analysts believe Constellation Brands, Inc. is more attractive than Molson Coors Beverage Co..

Constellation Brands, Inc. has a beta of 0.447, which suggesting that the stock is 55.311% less volatile than S&P 500. In comparison Molson Coors Beverage Co. has a beta of 0.453, suggesting its less volatile than the S&P 500 by 54.699%.

Constellation Brands, Inc. has a quarterly dividend of $1.02 per share corresponding to a yield of 2.77%. Molson Coors Beverage Co. offers a yield of 3.91% to investors and pays a quarterly dividend of $0.47 per share. Constellation Brands, Inc. pays 2353.06% of its earnings as a dividend. Molson Coors Beverage Co. pays out 32.91% of its earnings as a dividend. Molson Coors Beverage Co.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Constellation Brands, Inc.'s is not.

Constellation Brands, Inc. quarterly revenues are $2.2B, which are smaller than Molson Coors Beverage Co. quarterly revenues of $3B. Constellation Brands, Inc.'s net income of $522.2M is higher than Molson Coors Beverage Co.'s net income of -$2.9B. Notably, Constellation Brands, Inc.'s price-to-earnings ratio is 23.18x while Molson Coors Beverage Co.'s PE ratio is 9.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Constellation Brands, Inc. is 2.78x versus 0.87x for Molson Coors Beverage Co.. Usually stocks with elevated PS ratios are considered overvalued.